{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:08:01Z","timestamp":1791745681303,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":104,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["\u21162019.2525\/ICON\/VLAIO\/private-public funded\/Consortium"],"award-info":[{"award-number":["\u21162019.2525\/ICON\/VLAIO\/private-public funded\/Consortium"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01497-2","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:06:03Z","timestamp":1778857563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression"],"prefix":"10.1186","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-5771","authenticated-orcid":false,"given":"Murat","family":"Akand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alberto","family":"Nakauma-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Jatsenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Baldewijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris Robert","family":"Vermeesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"1497_CR1","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fonc.2019.01402","volume":"9","author":"M Akand","year":"2019","unstructured":"Akand M, Muilwijk T, Cornelissen J, Van Bruwaene S, Vander Eeckt K, Baekelandt F, et al. Development of a prospective data registry system for non-muscle-invasive bladder cancer patients incorporated in the electronic patient file system. Front Oncol. 2019;9:1402. https:\/\/doi.org\/10.3389\/fonc.2019.01402.","journal-title":"Front Oncol"},{"key":"1497_CR2","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.3390\/cancers\/16213653","volume":"16","author":"M Akand","year":"2024","unstructured":"Akand M, Veys R, Ost D, Vander Eeckt K, Baekelandt F, Van Reusel R, et al. Cohort profile: VZNKUL \u2013 NMIBC quality indicators program: a Flemish prospective cohort to evaluate the quality indicators in the treatment of non-muscle-invasive bladder cancer. Cancers. 2024;16:3653. https:\/\/doi.org\/10.3390\/cancers\/16213653.","journal-title":"Cancers"},{"key":"1497_CR3","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.3390\/cancers17193261","volume":"17","author":"E Albers Acosta","year":"2025","unstructured":"Albers Acosta E, PelariMici L, G\u00fcemez CM, Velasco Balanza C, Saavedra Centeno M, P\u00e9rez P\u00e9rez M, et al. Beyond visualization: advanced imaging, theragnostics and biomarker integration in urothelial bladder carcinoma. Cancers. 2025;17:3261. https:\/\/doi.org\/10.3390\/cancers17193261.","journal-title":"Cancers"},{"key":"1497_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk M, Burger M, Comperat E, Gontero P, Mostafid AH, Palou J, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1 and carcinoma in situ) \u2013 2019 update. Eur Urol. 2019;76:639\u201357. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.016.","journal-title":"Eur Urol"},{"key":"1497_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.celrep.2014.10.035","volume":"9","author":"A Biton","year":"2014","unstructured":"Biton A, Bernard-Pierrot I, Lou Y, Krucker C, Chapeaublanc E, Rubio-P\u00e9rez C, et al. Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal types. Cell Rep. 2014;9:1235\u201345. https:\/\/doi.org\/10.1016\/j.celrep.2014.10.035.","journal-title":"Cell Rep"},{"key":"1497_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates and incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1497_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo B, Zagorac S, Corral S, Margu\u00e9s M, Real FX. Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities. Eur Urol Oncol. 2023;6:366\u201375. https:\/\/doi.org\/10.1016\/j.euo.2023.02.011.","journal-title":"Eur Urol Oncol"},{"key":"1497_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jmoldx.2024.08.005","volume":"26","author":"EA Cotillas","year":"2024","unstructured":"Cotillas EA, Bernardo C, Veerla S, Liedberg F, Sj\u00f6dahl G, Eriksson P. A versatile and upgraded version of the LundTax classification algorithm applied to independent cohorts. J Mol Diagn. 2024;26:1081\u2013101. https:\/\/doi.org\/10.1016\/j.jmoldx.2024.08.005.","journal-title":"J Mol Diagn"},{"key":"1497_CR9","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. PNAS. 2014;111:3110\u20135. https:\/\/doi.org\/10.1073\/pnas.1318376111.","journal-title":"PNAS"},{"key":"1497_CR10","doi-asserted-by":"publisher","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.eabn4118","volume":"15","author":"FC de Jong","year":"2023","unstructured":"de Jong FC, Laajala TM, Hoedemaeker RF, Jordan KR, van der Made ACJ, Boev\u00e9 ER, et al. Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Gu\u00e9rin. Sci Trans Med. 2023;15:eabn4118. https:\/\/doi.org\/10.1126\/scitranslmed.eabn4118.","journal-title":"Sci Trans Med"},{"key":"1497_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18:9\u201334. https:\/\/doi.org\/10.1038\/s41571-020-0403-1.","journal-title":"Nat Rev Clin Oncol"},{"key":"1497_CR12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pineiro L, Gonzalez M, et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Gu\u00e9rin: the CUETO scoring model. J Urol. 2009;182:2195\u2013203. https:\/\/doi.org\/10.1016\/j.juro.2009.07.016.","journal-title":"J Urol"},{"key":"1497_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00262-018-2150-z","volume":"67","author":"F Finotello","year":"2018","unstructured":"Finotello F, Trajanoski Z. Quantifying tumor-infiltrating immune cells from transcriptomics data. Cancer Immunol Immunother. 2018;67:1031\u201340. https:\/\/doi.org\/10.1007\/s00262-018-2150-z.","journal-title":"Cancer Immunol Immunother"},{"key":"1497_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological methods of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11:34. https:\/\/doi.org\/10.1186\/s13073-019-0638-6.","journal-title":"Genome Med"},{"key":"1497_CR15","unstructured":"Food and Drug Administration Guidance Document: BCG-unresponsive nonmuscle invasive bladder cancer: Developing drugs and biologics for treatment (Guidance for industry).\u00a02018; reached at www.regulations.gov\/document\/FDA-2018-D-0342-0002."},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez Escrig JL, Liedberg F, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) \u2013 a summary of the 2024 guidelines update. Eur Urol. 2024;86:531\u201349. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.027.","journal-title":"Eur Urol"},{"key":"1497_CR17","doi-asserted-by":"publisher","first-page":"e19802","DOI":"10.1016\/j.heliyon.2023.e19802","volume":"9","author":"L Huang","year":"2023","unstructured":"Huang L, Xie Q, Deng J, Wei WF. The role of cancer-associated fibroblasts in bladder cancer progression. Heliyon. 2023;9:e19802. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19802.","journal-title":"Heliyon"},{"key":"1497_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamaoun","year":"2020","unstructured":"Kamaoun A, de Reynies A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020;77:420\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006.","journal-title":"Eur Urol"},{"key":"1497_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.devcel.2021.02.028","volume":"56","author":"Y Katsuno","year":"2021","unstructured":"Katsuno Y, Derynck R. Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-\u03b2 family. Dev Cell. 2021;56:726\u201346. https:\/\/doi.org\/10.1016\/j.devcel.2021.02.028.","journal-title":"Dev Cell"},{"key":"1497_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein. Science. 2010;330:827\u201330. https:\/\/doi.org\/10.1126\/science.1195300.","journal-title":"Science"},{"key":"1497_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1:417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"1497_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtr\u00f6der K, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021;12:2301. https:\/\/doi.org\/10.1038\/s41467-021-22465-w.","journal-title":"Nat Commun"},{"key":"1497_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s42003-025-08094-9","volume":"8","author":"Z Liu","year":"2025","unstructured":"Liu Z, Mao X, Xie Y, Yan Y, Wang X, Mi J, et al. Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer. Commun Biol. 2025;8:696. https:\/\/doi.org\/10.1038\/s42003-025-08094-9.","journal-title":"Commun Biol"},{"key":"1497_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.euo.2022.11.005","volume":"6","author":"T Muilwijk","year":"2023","unstructured":"Muilwijk T, Akand M, Raskin Y, Jorissen C, Vander Eeckt K, Van Bruwaene S, et al. Quality control indicators for transurethral resection of bladder tumor: results from an embedded Belgian multicenter prospective registry. Eur Urol Oncol. 2023;6:422\u201330. https:\/\/doi.org\/10.1016\/j.euo.2022.11.005.","journal-title":"Eur Urol Oncol"},{"key":"1497_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euros.2024.06.011","volume":"66","author":"T Muilwijk","year":"2024","unstructured":"Muilwijk T, Baekelandt L, Akand M, Daelemans S, Marien K, Waumans Y, et al. Fibroblast activation protein-\u03b1 and the immune landscape: unraveling T1 non-muscle-invasive bladder cancer progression. Eur Urol Open Sci. 2024;66:67\u201374. https:\/\/doi.org\/10.1016\/j.euros.2024.06.011.","journal-title":"Eur Urol Open Sci"},{"key":"1497_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.eururo.2022.01.026","volume":"81","author":"JA Nakauma-Gonz\u00e1lez","year":"2022","unstructured":"Nakauma-Gonz\u00e1lez JA, Rijnders M, van Riet J, van der Heijden MS, Voortman J, Cuppen E, et al. Comprehensive molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma. Eur Urol. 2022;81:331\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.026.","journal-title":"Eur Urol"},{"key":"1497_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2967\/jnumed.125.271080","volume":"00","author":"E Novruzov","year":"2026","unstructured":"Novruzov E, Mamlins E, Widjaja L, Siegmund SC, Watabe T, Mori Y, et al. Reliability and practicability of DAP-RADS version 1.0 for structured reporting of FAPI imaging of pulmonary and urothelial carcinoma. J Nucl Med. 2026;00:1\u20136. https:\/\/doi.org\/10.2967\/jnumed.125.271080.","journal-title":"J Nucl Med"},{"key":"1497_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","volume":"78","author":"AG Robertson","year":"2020","unstructured":"Robertson AG, Groeneveld CS, Jordan B, Lin X, McLaughlin KA, Das A, et al. Identification of differential tumor subtypes of T1 bladder cancer. Eur Urol. 2020;78:533\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2020.06.048.","journal-title":"Eur Urol"},{"key":"1497_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"key":"1497_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"1497_CR31","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, Lauss M, L\u00f6vgren K, Chebil G, Gudjonsson S, Veerla S, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18:3377\u201386. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0077-T.","journal-title":"Clin Cancer Res"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.05006580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.05006580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1497_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta, T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466\u201375. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031.","journal-title":"Eur Urol"},{"key":"1497_CR34","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1007\/s00259-025-07239-6","volume":"52","author":"LM Unterrainer","year":"2025","unstructured":"Unterrainer LM, Schmid HP, Kunte SC, Holzgreve A, Toms J, Menold P, et al. 68Ga-FAPI and 18F-FAPI PET\/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients. Eur J Nucl Med Mol Imaging. 2025;52:3963\u201374. https:\/\/doi.org\/10.1007\/s00259-025-07239-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1497_CR35","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.10168\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, Wang Z, Wang H, He C, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiosarcoma. J Hepatology. 2020;73:1118\u201330. https:\/\/doi.org\/10.10168\/j.jhep.2020.05.039.","journal-title":"J Hepatology"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01497-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:16:14Z","timestamp":1787793374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01497-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01497-2","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved human participants and was approved by the Ethics Committee Research UZ\/KU Leuven (approval date: 25\/07\/2022, approval number: S66536). This retrospective study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"136"}}